Daré Bioscience Presents Sildenafil Cream Study at Menopause Society Annual Meeting

PUBT · 1d ago
Daré Bioscience Presents Sildenafil Cream Study at Menopause Society Annual Meeting
  • Daré Bioscience will sponsor HERmedicine’s Managing Menopause After Breast Cancer program on Oct. 20, 2026, in San Diego.
  • The company will attend The Menopause Society’s annual meeting Oct. 20-24, 2026, with a Phase 1 Sildenafil Cream, 3.6% presentation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dare Bioscience Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610190856PRIMZONEFULLFEED9847834) on October 19, 2026, and is solely responsible for the information contained therein.